Clinical trials
Lymphoma, B-Cell, Marginal Zone trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 5 |
| 2005 | 3 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 4 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jonsson Comprehensive Cancer Center | 3 |
| National Taiwan University Hospital | 3 |
| Gilead Sciences | 2 |
| Herbert Irving Comprehensive Cancer Center | 2 |
| University of California, Davis | 2 |
| Auxilio Mutuo Cancer Center | 1 |
| Chinese PLA General Hospital | 1 |
| Clatterbridge Centre for Oncology | 1 |
| Dong-A University Hospital | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell, Marginal Zone | 50 |
| Lymphoma, Follicular | 37 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 30 |
| Lymphoma, Mantle-Cell | 29 |
| Lymphoma, Non-Hodgkin | 29 |
| Lymphoma | 28 |
| Lymphoma, Large B-Cell, Diffuse | 28 |
| Burkitt Lymphoma | 23 |
| Lymphoma, Large-Cell, Immunoblastic | 22 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 22 |
Trials
Showing 26 to 50 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.